Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Accuracy of recall of information about a cancer-predisposing BRCA1/2 gene mutation among patients and relatives.

Jacobs C, Dancyger C, Smith JA, Michie S.

Eur J Hum Genet. 2014 May 21. doi: 10.1038/ejhg.2014.84. [Epub ahead of print]

PMID:
24848747
[PubMed - as supplied by publisher]
2.
3.

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.

Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, Dugast C, Berthet P, de Paillerets BB, Sobol H, Grandjouan S, Soubrier F, Buecher B, Guimbaud R, Lidereau R, Jonveaux P, Houdayer C, Giraud S, Olschwang S, Nogue E, Galibert V, Bara C, Nowak F, Khayat D, Nogues C.

Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24.

PMID:
23974829
[PubMed - indexed for MEDLINE]
4.

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.

Gronwald J, Huzarski T, Byrski B, Medrek K, Menkiszak J, Monteiro AN, Sun P, Lubinski J, Narod SA.

J Med Genet. 2006 May;43(5):424-8. Epub 2005 Oct 14.

PMID:
16227521
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306
[PubMed - indexed for MEDLINE]
6.

BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.

Cherbal F, Salhi N, Bakour R, Adane S, Boualga K, Maillet P.

Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.

PMID:
22684231
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.

Fischer C, Kuchenbäcker K, Engel C, Zachariae S, Rhiem K, Meindl A, Rahner N, Dikow N, Plendl H, Debatin I, Grimm T, Gadzicki D, Flöttmann R, Horvath J, Schröck E, Stock F, Schäfer D, Schwaab I, Kartsonaki C, Mavaddat N, Schlegelberger B, Antoniou AC, Schmutzler R; German Consortium for Hereditary Breast and Ovarian Cancer.

J Med Genet. 2013 Jun;50(6):360-7. doi: 10.1136/jmedgenet-2012-101415. Epub 2013 Apr 6.

PMID:
23564750
[PubMed - indexed for MEDLINE]
8.

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De Grève J.

BMC Med Genet. 2008 Sep 10;9:83. doi: 10.1186/1471-2350-9-83.

PMID:
18783588
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E.

Am J Med Genet A. 2003 Jan 1;116A(1):11-9.

PMID:
12476445
[PubMed - indexed for MEDLINE]
10.

Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.

Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P, Rantanen E, Kääriäinen H, Mecklin JP.

J Med Genet. 2007 Nov;44(11):732-8. Epub 2007 Jul 14.

PMID:
17630403
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID:
15863145
[PubMed - indexed for MEDLINE]
12.

Communicating genetics research results to families: problems arising when the patient participant is deceased.

Ormondroyd E, Moynihan C, Ardern-Jones A, Eeles R, Foster C, Davolls S, Watson M.

Psychooncology. 2008 Aug;17(8):804-11. doi: 10.1002/pon.1356.

PMID:
18688787
[PubMed - indexed for MEDLINE]
13.

Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.

Seymour IJ, Casadei S, Zampiga V, Rosato S, Danesi R, Scarpi E, Falcini F, Strada M, Morini N, Naldoni C, Amadori D, Calistri D.

Breast Cancer Res Treat. 2008 Nov;112(2):343-9. Epub 2007 Dec 20.

PMID:
18092194
[PubMed - indexed for MEDLINE]
14.

Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Bodd TL, Reichelt J, Heimdal K, Moller P.

J Genet Couns. 2003 Oct;12(5):405-17.

PMID:
14758817
[PubMed - indexed for MEDLINE]
15.

Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland.

Holloway SM, Bernhard B, Campbell H, Cetnarskyj R, Lam WW.

Fam Cancer. 2008;7(3):259-64. doi: 10.1007/s10689-008-9184-x. Epub 2008 Feb 2.

PMID:
18246448
[PubMed - indexed for MEDLINE]
16.

Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.

Julian-Reynier C, Sobol H, Sévilla C, Noguès C, Bourret P; French Cancer Genetic Network.

Psychooncology. 2000 Nov-Dec;9(6):504-10.

PMID:
11180585
[PubMed - indexed for MEDLINE]
17.

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.

Sanz J, Ramón y Cajal T, Torres A, Darder E, Gadea N, Velasco A, Fortuny D, López C, Fisas D, Brunet J, Alonso MC, Balmaña J.

Fam Cancer. 2010 Sep;9(3):297-304. doi: 10.1007/s10689-009-9313-1.

PMID:
20091130
[PubMed - indexed for MEDLINE]
18.

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER.

BMC Cancer. 2008 May 30;8:155. doi: 10.1186/1471-2407-8-155.

PMID:
18513387
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Risk assessment for familial occurrence of breast cancer].

Chang-Claude J, Becher H, Hamann U, Schroeder-Kurth T.

Zentralbl Gynakol. 1995;117(8):423-34. German.

PMID:
7571905
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk